Resources / Advanced image analysis capabilities to enhance drug discovery
Oncotopix® Discovery
Duration 54 min
Brit Boehmer and Brenna O´Neill, Visiopharm
Advanced image analysis capabilities to enhance drug discovery
Details
Duration 54 min
Description

Join Brit and Brenna from Visiopharm as they delve into our comprehensive AI toolbox for histopathology image assessment. They will begin by discussing the implementation of deep learning algorithms for maximizing data from multiplex phenotypic analysis. Discover how Visiopharm’s ease of use and robustness make it the ideal solution for even the toughest challenges.

Learning objectives
    • Simplifying deep learning algorithms for complex feature analysis
    • Iterative approach to enhance the success of deep learning applications
    • Maximizing workflow efficiency and accuracy through APP sequences and integrations
    • Optimizing applications to tackle analytical challenges
    • Providing platform-agnostic solutions for multiplex phenotyping data sets
    • Practical benefits of using digital histopathology workflows
Experts

Brit Boehmer, Technical Sales Specialist, Sales US, Visiopharm

Brit Boehmer is an Account Executive for the US West based in Denver, CO. He has a master’s and Ph.D. in physiology from Oklahoma State University and completed postdoctoral research in reproduction, nutrition and fetal growth. Brit joined Visiopharm in 2020 and supports clients with pre-sale APP development and advice on image analysis and histopathology workflows.

Brenna O’Neill, Technical Sales Specialist, Sales US, Visiopharm

Brenna O’Neill is the Technical Sales Specialist for the US West, based in Visiopharm’s Westminster, CO office. She has a master’s in ecology and over 10 years of imaging experience across multiple platforms, including 3 years in image analysis. As a Technical Sales Specialist, Brenna supports clients with software demonstrations and pre-sale APP development to address their image analysis needs.

Questions? We’re here to help.
Contact us
Success
Your message has been successfully sent!